AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Bioworld Financial Watch articles from April 2004

3,200 total articles

Set up an RSS feed
Close Set up an RSS feed that alerts you when new articles from Bioworld Financial Watch are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds
to find out when new articles for Bioworld Financial Watch arrive.

Bioworld Financial Watch archives from April 2004

LDA trying to build a better biotech industry in London.
April 5, 2004... LONDON -- Walk into any pub in London, ask about biotechnology and you'll get varying answers. One woman said she was "a bit unsure" about the science, scrunching her nose. She also expressed distrust for the government. "They say one...

10 biggest U.S. gainers for the week.
April 5, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Tularik 45.24 Alliance 37.84 Genelabs 32.11 Cel-Sci 29.21 ArQule 26.37 Myogen 25.71 Rigel ...

10 biggest U.S. losers for the week.
April 5, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) SuperGen -32.02 LION bioscience -16.36 Avigen -13.90 Transgenomic -11.17 Cygnus -10.34 Miravant -9.77 Acusphere -9.24...

Grants, contracts and awards to biotech companies: Oct. 17, 2003-March 31, 2004.
April 5, 2004... Grants, Contracts And Awards To Biotech Companies: Oct. 17, 2003 - March 31, 2004 Company * Funding Amount (Country; Symbol) Institution (M) Acacia Department ...

BioWorld stock report for public biotechnology companies.
April 5, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 3/26 4/2 Aastrom Biosci ASTM 1.33 1.33 Abgenix ABGX 12.99 ...

Obesity's former magic bullet leptin offered lessons aplenty.
April 12, 2004... SAN FRANCISCO -- Remember leptin? The once-ballyhooed hormone and its receptor technology that Amgen Inc. licensed from Progenitor Inc. way back in 1997 had gained the limelight as a potential obesity cure two years earlier. Molecular...

10 biggest U.S. gainers for the week.
April 12, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Incara Pharma 22.86 ImClone Sys 4.32 V.I. Technol 14.66 Martek Bio 3.00 Argonaut 14.48 Immtech ...

10 biggest U.S. losers for the week.
April 12, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Viragen -18.18 Rigel -3.45 Miravant -16.11 Pharmacopeia -3.28 Rigel -14.86 Biogen IDEC ...

Public financing of biotechnology: March 2004.
April 12, 2004... Public Financing Of Biotechnology: March 2004 I. COMMENCED TRADING IN MARCH Company Date Date Shares/ (Symbol) (#) Filed Comm. Units (M) INITIAL OFFERINGS Anadys 11/17/03...

Other financings of public biotechnology companies: March 2004.
April 12, 2004... Other Financings Of Public Biotechnology Companies: March 2004 TOTAL: $710.16M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: March 2004.
April 12, 2004... Venture Capital And Corporate Investments In Biotechnology Companies: March 2004 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $795.55 Company Location Date Amt. (M) A&G Columbia, Md....

Money raised by biotech in 2004: January-March.
April 12, 2004... Money Raised By Biotech In 2004: January-March Type of financing Jan. ($M) Feb. (M) Mar. (M) Total ($M) Public offerings 352.1 997.8 586.6 1,936.4 Private biotechs 444.3 367.0 ...

BioWorld stock report for public biotechnology companies.
April 12, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 2-4 8-4 Aastrom Biosci ASTM 1.33 1.14 Abgenix ...

Late-stage scarcity, checkpoint work helped ArQule seal deal.
April 19, 2004... Patrol the border of cancer therapy in biotechnology and you're likely to find compounds based on cell-cycle checkpoints--the stopping and starting points in a cell's division--among the prospects hoping to make their way into the "promised...

10 biggest U.S. gainers for the week.
April 19, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Large Scale 19.47 Biogen IDEC 4.43 Indevus 16.74 Eyetech 2.87 Genome Thera 12.52 ...

10 biggest U.S. losers for the week.
April 19, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Imcor -42.59 Invitrogen -4.67 Northwest BioThera -35.71 ICOS -3.45 Hybridon ...

Clinical trials update: March 2004.
April 19, 2004... Clinical Trials Update: March 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Amgen Inc. (AMGN) HuMax-IL15/ Human antibody against and Genmab A/S AMG 714 interleukin-15...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: March 2004.
April 19, 2004... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: March 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Serono SA Raptiva Efalizumab;...

FDA submissions, approvals and other actions: March 2004.
April 19, 2004... FDA Submissions, Approvals And Other Actions: March 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Human Genome LymphoStat-B Human monoclonal antibody Sciences Inc. ...

BioWorld stock report for public biotechnology companies.
April 19, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 4/8 4/16 WK YTD (000) Aastrom Biosci ASTM 1.14...

Visionary Eyetech saw aptamers' value, turned Macugen into gold.
April 26, 2004... Eyetech Pharmaceuticals Inc.'s CEO David Guyer typically is humble when he talks about the company's landmark potential $750 million deal in late 2002 with Pfizer Inc. for Macugen, the in-licensed aptamer for age-related macular degeneration....

10 biggest U.S. gainers for the week.
April 26, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Incara Pharma 57.78 ImClone Sys 11.03 Zonagen 36.40 Genentech 9.44 ImmunoGen 25.69 Martek Bio ...

10 biggest U.S. losers for the week.
April 26, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Northwest BioThera -77.78 Affymetrix -3.62 Avax Technol -30.30 Amgen -1.83 Sonus Pharma ...

Biotech-big pharma collaborations: new agreements, Feb. 20-April 21, 2004 (#).
April 26, 2004... Biotech-Big Pharma Collaborations: New Agreements, Feb. 20 - April 21, 2004 (#) Biotech Co. * Pharma Co. Type/Product Area (Country; Symbol) (Country) Accelrys Inc. Henkel KGaA Three-year license deal...

Manufacturing, marketing and distribution agreements between Biotech and Pharmaceutical Companies: Feb. 20-April 21, 2004 (#).
April 26, 2004... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Feb. 20 - April 21, 2004 (#) Biotech Co. * Pharma Co. Product (Country; Symbol) (Country) Alliance IL Yang...

Biotech-big pharma collaborations: modified and terminated agreements, Feb. 20-April 21, 2004 (#).
April 26, 2004... Biotech-Big Pharma Collaborations: Modified And Terminated Agreements, Feb. 20 - April 21, 2004 (#) I. MODIFIED AGREEMENTS Biotech Co. * Pharma Co. Change from original (Country; Symbol) (Country) agreement ...

BioWorld stock report for public biotechnology companies.
April 26, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 4/16 4/23 Abgenix ABGX 13.83 14.7 Pharmacopeia ...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA